TREATMENT FOR NON-ALCOHOLIC FATTY LIVER DISEASES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20190314328A1
SERIAL NO

16453934

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Mixtures of vitamin E and polyunsaturated fatty acids (PUFAs) are provided as agents for the prevention, control and/or treatment of conditions associated with excessive fat accumulation in the liver which is not caused by alcohol abuse, including control and/or treatment of non-alcoholic steatosis in the liver—known as non-alcoholic fatty liver disease (NAFLD)—and/or non-alcoholic steatohepatitis (NASH) in a subject in need thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DSM IP ASSETS B VHOLLAND HEERLEN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
PETER, Szabolcs Kaiseraugst, CH 5 0
SCHWAGER, Joseph Kaiseraugst, CH 29 76

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation